Inflammatory bowel disease is characterized by significant interindividual heterogeneity.
With a wider selection of pharmacologic and nonpharmacologic interventions available and …

Background Inflammatory bowel diseases [IBD], which are associated with a high disease
burden, are also reported to be accompanied by a high prevalence of psychiatric disorders …

Background Inflammatory bowel disease (IBD) is associated with psychiatric diseases, but it
is unclear to what degree patients with IBD are affected over their lifetime. We aimed to …

Gut microbiota dysbiosis is strongly associated with psychiatric disorders and inflammatory
bowel disease (IBD). Herein, we examined whether the fecal microbiota of IBD patients with …

Background Patients with active inflammatory bowel disease (IBD) and mental illnesses
experience worse IBD outcomes. Aim To describe the incidence of mental illnesses …

Background Neurological involvement and psychiatric manifestations have been
documented in clinical cases of inflammatory bowel disease (IBD); however, the presence of …

Background Constipation is generally considered a common physical symptom of
depression or a side effect of antidepressant treatments. However, according to the gut-brain …

Background Gut microbiome and inflammatory bowel disease (IBD) are implicated in the
development of depression, but the effect of their interactions on the risk of depression …

Background Psychiatric disorders in patients with inflammatory bowel disease (IBD)
represent a significant but uncertain facet of the disease, with unsolved questions regarding …

Inflammatory bowel disease can cause pathological changes of certain organs, including
the gut and brain. As the major degradation route of tryptophan (Trp), Kynurenine (Kyn) …